Union européenne -
français -
EMA (European Medicines Agency)
evkeeza
ultragenyx germany gmbh - evinacumab - hypercholestérolémie - agents de modification des lipides - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).
Canada -
français -
Health Canada
evkeeza solution
ultragenyx pharmaceutical inc - Évinacumab - solution - 150mg - Évinacumab 150mg
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
hemlibra 30mg/1ml solution injectable
roche pharma (schweiz) ag - emicizumabum - solution injectable - emicizumabum 30 mg, histidinum, acidum asparticum ad ph, argininum, poloxamerum 188, aqua ad iniectabile ad solutionem pro 1 ml. - l'hémophilie a - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
hemlibra 60mg/0.4ml solution injectable
roche pharma (schweiz) ag - emicizumabum - solution injectable - emicizumabum 60 mg, histidinum, acidum asparticum ad ph, argininum, poloxamerum 188, aqua ad iniectabile ad solutionem pro 0.4 ml. - l'hémophilie a - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
hemlibra 105mg/0.7ml solution injectable
roche pharma (schweiz) ag - emicizumabum - solution injectable - emicizumabum 105 mg, histidinum, acidum asparticum ad ph, argininum, poloxamerum 188, aqua ad iniectabile ad solutionem pro 0.7 ml. - l'hémophilie a - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
hemlibra 150mg/1ml solution injectable
roche pharma (schweiz) ag - emicizumabum - solution injectable - emicizumabum 150 mg, histidinum, acidum asparticum ad ph, argininum, poloxamerum 188, aqua ad iniectabile ad solutionem pro 1 ml. - l'hémophilie a - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
repatha 120mg/ml injektionslösung in einer patrone
amgen switzerland ag - evolocumabum - injektionslösung in einer patrone - evolocumabum 120 mg, prolinum, acidum aceticum glaciale, polysorbatum 80, aqua ad iniectabilia q.s. ad solutionem pro 1 ml. - blutlipidsenkende mittel - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
repatha 140 mg / ml stylo prérempli
amgen switzerland ag - evolocumabum - stylo prérempli - evolocumabum 140 mg, prolinum, acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml. - blutlipidsenkende moyens - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
aimovig 70 mg/ml solution injectable dans une seringue préremplie
novartis pharma schweiz ag - erenumabum - solution injectable dans une seringue préremplie - erenumabum 70 mg, saccharum, polysorbatum 80, acidum aceticum glaciale, natrii hydroxidum, natrium 0.2 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - migräneprophylaxe - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
aimovig 140 mg/ml solution injectable dans une seringue préremplie
novartis pharma schweiz ag - erenumabum - solution injectable dans une seringue préremplie - erenumabum 140 mg, saccharum, polysorbatum 80, acidum aceticum glaciale, natrii hydroxidum, natrium 0.2 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - migräneprophylaxe - biotechnologika